Mina S. Sedrak

3.6k total citations · 2 hit papers
104 papers, 2.0k citations indexed

About

Mina S. Sedrak is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Geriatrics and Gerontology. According to data from OpenAlex, Mina S. Sedrak has authored 104 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 31 papers in Pulmonary and Respiratory Medicine and 22 papers in Geriatrics and Gerontology. Recurrent topics in Mina S. Sedrak's work include Frailty in Older Adults (22 papers), Health Systems, Economic Evaluations, Quality of Life (16 papers) and Advanced Breast Cancer Therapies (15 papers). Mina S. Sedrak is often cited by papers focused on Frailty in Older Adults (22 papers), Health Systems, Economic Evaluations, Quality of Life (16 papers) and Advanced Breast Cancer Therapies (15 papers). Mina S. Sedrak collaborates with scholars based in United States, Mexico and Netherlands. Mina S. Sedrak's co-authors include William Dale, Harvey Jay Cohen, Jennifer Liu, Simran Padam, Kevin George, Can‐Lan Sun, Daneng Li, Supriya G. Mohile, Andrew R. Wong and Vani Katheria and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Mina S. Sedrak

98 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Older adult participation in cancer clinical trials: A systematic review of barriers and interventions

2020 287 citations Mina S. Sedrak, Rachel A. Freedman et al. CA A Cancer Journal for Clinicians profile →
Geriatric Assessment–Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer

2021 236 citations Daneng Li, Can‐Lan Sun et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mina S. Sedrak United States	21	711	499	417	391	391	104	2.0k
Johanneke E.A. Portielje Netherlands	33	1.7k 2.4×	628 1.3×	571 1.4×	280 0.7×	249 0.6×	144	3.4k
Cynthia Owusu United States	26	1.6k 2.3×	1.4k 2.9×	685 1.6×	609 1.6×	501 1.3×	92	3.5k
Rachel A. Freedman United States	32	2.4k 3.4×	242 0.5×	822 2.0×	503 1.3×	360 0.9×	186	4.0k
Margaret Kemeny United States	23	1.4k 1.9×	162 0.3×	494 1.2×	296 0.8×	295 0.8×	71	2.7k
Ulrich Wedding Germany	30	1.5k 2.1×	1.2k 2.3×	808 1.9×	429 1.1×	722 1.8×	156	3.5k
Carolyn J. Presley United States	24	1.2k 1.7×	228 0.5×	566 1.4×	206 0.5×	275 0.7×	150	2.0k
Gabrielle B. Rocque United States	27	1.3k 1.8×	146 0.3×	295 0.7×	514 1.3×	967 2.5×	209	2.6k
Janette K. Merrill United States	14	839 1.2×	126 0.3×	173 0.4×	124 0.3×	359 0.9×	33	1.7k
Joy H. Lewis United States	14	455 0.6×	143 0.3×	215 0.5×	246 0.6×	407 1.0×	48	1.6k
Lisa M. Hess United States	24	785 1.1×	165 0.3×	796 1.9×	330 0.8×	144 0.4×	145	2.4k

Countries citing papers authored by Mina S. Sedrak

Since Specialization

Citations

This map shows the geographic impact of Mina S. Sedrak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mina S. Sedrak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mina S. Sedrak more than expected).

Fields of papers citing papers by Mina S. Sedrak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mina S. Sedrak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mina S. Sedrak. The network helps show where Mina S. Sedrak may publish in the future.

Co-authorship network of co-authors of Mina S. Sedrak

This figure shows the co-authorship network connecting the top 25 collaborators of Mina S. Sedrak. A scholar is included among the top collaborators of Mina S. Sedrak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mina S. Sedrak. Mina S. Sedrak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bardia, Aditya, Hope S. Rugo, Mina S. Sedrak, et al.. (2025). Q-TWiST Analysis to Assess Benefit-Risk of Sacituzumab Govitecan in Previously Treated Patients With Metastatic Triple-Negative Breast Cancer. JCO Oncology Practice. OP2400806–OP2400806. 1 indexed citations

Balogh, Erin P., Laura A. Levit, Joseph M. Unger, et al.. (2025). ASCO State of Cancer Care in America Special Report 2025: Access to Cancer Clinical Trials in the United States. JCO Oncology Practice. 21(12). 1746–1758.

Rubio, Alicia, Mina S. Sedrak, Susan A. McCloskey, et al.. (2025). Impact of Screening Mammography on Breast Cancer Outcomes in Women Aged 80 Years and Over. Annals of Surgical Oncology. 33(1). 129–137.

Mandelblatt, Jeanne S., Michael H. Antoni, Traci N. Bethea, et al.. (2024). Gerotherapeutics: aging mechanism–based pharmaceutical and behavioral interventions to reduce cancer racial and ethnic disparities. JNCI Journal of the National Cancer Institute. 117(3). 406–422. 3 indexed citations

Jones, Veronica, Linda D. Bosserman, Sayeh Lavasani, et al.. (2024). UGT1A1*28 polymorphism and the risk of toxicity and disease progression in patients with breast cancer receiving sacituzumab govitecan. Cancer Medicine. 13(16). e70096–e70096. 6 indexed citations

Daniel, Ebenezer, Sunita K. Patel, Mina S. Sedrak, et al.. (2024). Altered gyrification in chemotherapy‐treated older long‐term breast cancer survivors. Brain and Behavior. 14(8). e3634–e3634. 3 indexed citations

Ji, Jingran, et al.. (2024). A phase II randomized double-blind placebo-controlled study of fisetin to improve physical function in frail older breast cancer survivors (TROFFi).. Journal of Clinical Oncology. 42(16_suppl). TPS1645–TPS1645. 2 indexed citations

Behrendt, Carolyn E., Susan E. Yost, Niki Patel, et al.. (2023). Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast Cancer. The Oncologist. 28(7). e488–e492. 5 indexed citations

Lavasani, Sayeh, Mina S. Sedrak, Daphne Stewart, et al.. (2023). Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer. Journal of Clinical Medicine. 12(5). 1906–1906.

10.

Patel, Sunita K., Mina S. Sedrak, Heeyoung Kim, et al.. (2023). Brain white matter microstructural changes in chemotherapy‐treated older long‐term breast cancer survivors. Cancer Medicine. 13(1). e6881–e6881. 8 indexed citations

11.

Dale, William, et al.. (2023). Facilitators and Barriers to Older Adult Participation in Cancer Trials: A Qualitative Study Exploring Patient-Caregiver Dyad Congruence. JCO Oncology Practice. 19(7). 484–492. 2 indexed citations

12.

Sedrak, Mina S. & Harvey Jay Cohen. (2022). The Aging–Cancer Cycle: Mechanisms and Opportunities for Intervention. The Journals of Gerontology Series A. 78(7). 1234–1238. 18 indexed citations

13.

Chen, Bihong T., Zikuan Chen, Sunita K. Patel, et al.. (2022). Signal Variability and Cognitive Function in Older Long-Term Survivors of Breast Cancer with Exposure to Chemotherapy: A Prospective Longitudinal Resting-State fMRI Study. Brain Sciences. 12(10). 1283–1283. 2 indexed citations

14.

Kimmick, Gretchen, Mina S. Sedrak, Grant R. Williams, et al.. (2022). Infrastructure to Support Accrual of Older Adults to National Cancer Institute Clinical Trials. JNCI Monographs. 2022(60). 151–158. 2 indexed citations

15.

Miyano, Masaru, Rosalyn W. Sayaman, Parijat Senapati, et al.. (2021). Breast-Specific Molecular Clocks Comprised ofELF5Expression and Promoter Methylation Identify Individuals Susceptible to Cancer Initiation. Cancer Prevention Research. 14(8). 779–794. 14 indexed citations

16.

Mortimer, Joanne, Laura Kruper, Mary Cianfrocca, et al.. (2020). Use of HER2-Directed Therapy in Metastatic Breast Cancer and How Community Physicians Collaborate to Improve Care. Journal of Clinical Medicine. 9(6). 1984–1984. 3 indexed citations

17.

Sedrak, Mina S., Rachel A. Freedman, Harvey Jay Cohen, et al.. (2020). Older adult participation in cancer clinical trials: A systematic review of barriers and interventions. CA A Cancer Journal for Clinicians. 71(1). 78–92. 287 indexed citations breakdown →

18.

Cushman, Taylor R., Bernard L. Jones, David Akhavan, et al.. (2020). The Effects of Time to Treatment Initiation for Patients With Non–small-cell Lung Cancer in the United States. Clinical Lung Cancer. 22(1). e84–e97. 24 indexed citations

19.

Chen, Bihong T., Sunita K. Patel, Ningrong Ye, et al.. (2019). Intrinsic brain activity changes associated with adjuvant chemotherapy in older women with breast cancer: a pilot longitudinal study. eScholarship (California Digital Library). 1 indexed citations

20.

Sedrak, Mina S., Jennifer S. Myers, Dylan S. Small, et al.. (2017). Effect of a Price Transparency Intervention in the Electronic Health Record on Clinician Ordering of Inpatient Laboratory Tests. ScholarlyCommons (University of Pennsylvania). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact